Outcome of enterococcal prosthetic joint infection: Is combination systemic therapy superior to monotherapy?

Clinical Infectious Diseases

Volumn 47, Issue 7, 2008, Pages 903-909

  El Helou, Odette C ^a   Berbari, Elie F ^a,c   Marculescu, Camelia E ^b   El Atrouni, Wissam I ^a   Razonable, Raymund R ^a   Steckelberg, James M ^a   Hanssen, Arlen D ^a   Osmon, Douglas R ^a  

^a Mayo Clinic   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DEBRIDEMENT; ENTEROCOCCAL INFECTION; FEMALE; HUMAN; JOINT PROSTHESIS; MALE; MONOTHERAPY; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; PROSTHESIS INFECTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; ENTEROCOCCUS; FEMALE; HIP PROSTHESIS; HUMANS; JOINT PROSTHESIS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 52449125640     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/591536     Document Type: Article

References (27)

1. Kurtz SM, Ong KL, Schmier J, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg 2007; 89(Suppl 3):144-51.
2. Lidgren L, Knutson K, Stefansdottir A. Infection and arthritis: infection of prosthetic joints. Best Pract Res Clin Rheumatol 2003; 17:209-18.
3. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis Clin North Am 2005; 19:885-914.
4. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Waldvogel FA, Bisno AL, ed. Infections associated with indwelling medical devices. 3rd ed. Washington, DC: American Society of Microbiology, 2000: 173-200.
5. Raymond NJ, Henry J, Workowski KA. Enterococcal arthritis: case report and review. Clin Infect Dis 1995; 21:516-22.
6. Ries MD. Vancomycin-resistant Enterococcus infected total knee arthroplasty. J Arthroplasty 2001; 16:802-5.
7. Tarr PE, Sakoulas G, Ganesan A, Smith MA, Lucey DR. Hematogenous enterococcal vertebral osteomyelitis: report of 2 cases and review of the literature. J Infect 2004; 48:354-62.
8. Berbari EF, Osmon DR, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42:216-23.
9. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42:471-8.
10. Wilson WR. Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci. Clin Microbiol Infect 1998; 4(Suppl 3):S17-26.
11. Weinstein AJ, Moellering RC Jr. Penicillin and gentamicin therapy for enterococcal infections. JAMA 1973; 223:1030-2.
12. Moellering RC Jr, Wennersten C, Weinberg AN. Synergy of penicillin and gentamicin against enterococci. J Infect Dis 1971; 124(Suppl):S207-9.
13. Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002; 34:159-66.
14. Sandoe JA, Witherden IR, Au-Yeung HK, Kite P, Kerr KG, Wilcox MH. Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases. J Antimicrob Chemother 2002; 50:577-82.
15. Gilbert D. Aminoglycoside. In: Mandell GL BJ, Dolin R, ed. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 6th ed. Vol. 1. Philadelphia: Elsevier Churchill Livingston, 2005:328-55.
16. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity: a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother 1984; 13(Suppl A):9-22.
17. Ilstrup D. Statistical considerations and the science of surveillance. In: Churchill-Livingston, ed. Reconstructive surgery of the joints. New York: Churchill-Livingston, 1996:225-301.
18. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981; 245:54-63.
19. Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007; 45:1113-9.
20. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
21. Wilson WR, Giuliani ER, Geraci JE. Treatment of penicillin-sensitive streptococcal infective endocarditis. Mayo Clin Proc 1982; 57:95-100.
22. Herzstein J, Ryan JL, Mangi RJ, Greco TP, Andriole VT. Optimal therapy for enterococcal endocarditis. Am J Med 1984; 76:186-91.
23. Goetz MB, Sayers J. Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicrob Chemother 1993; 32:325-34.
24. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394-434.
25. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274:1706-13.
26. Rao N, Regalla DM. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop Relat Res 2006; 451:34-7.
27. Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR. Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 1999; 74:553-8.